NCT04996810View on ClinicalTrials.gov

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

April 2, 2021

Study Completion Date

May 26, 2021

Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL

PROTOXIN

Botulinum toxin Type A

BIOLOGICAL

Botox®

Botulinum toxin Type A

Trial Locations (2)

Unknown

Chung-Ang University Hospital, Seoul

Nowon Eulji Medical Center, Seoul

All Listed Sponsors
lead

Protox Inc.

INDUSTRY

NCT04996810 - The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines | Biotech Hunter | Biotech Hunter